Mika Health, an oncology-focused digital therapeutics company, has partnered with pharma companies AstraZeneca and Daiichi Sankyo to provide digital therapeutics to women undergoing breast cancer treatments through a program called “UNITE.” The Mika Health app offers psychological support, medication tracking, reminders, education, and nutrition advice personalized to each patient’s specific type of cancer. The partnership will allow Mika Health’s offerings to be used alongside pharmaceutical therapy, starting with German-speaking patients in Switzerland before expanding to other regions. Mika Health has also partnered with other organizations to provide free access to their digital therapeutic services for cancer patients and their caregivers, including AI-enabled biomarker testing and clinical trial matching.
Source link
Mika Health partners with pharma giants for women’s oncology initiative
